MACK

Merrimack Pharmaceuticals, Inc.
MACK

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

MACK was delisted on the 17th of May, 2024.

Back to rankings

38 hedge funds and large institutions have $29.5M invested in Merrimack Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

82% less call options, than puts

Call options by funds: $180K | Put options by funds: $990K

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
38
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$180K
Puts
$990K
Net Calls
Net Calls Change

Top Buyers

1
+$107K
2
+$52K
3
+$50.1K
4
BlackRock
BlackRock
New York
+$6.31K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$6.01K

Top Sellers

1
-$380K
2
-$168K
3
-$152K
4
CAN
Cetera Advisor Networks
California
-$65K
5
Citadel Advisors
Citadel Advisors
Florida
-$51K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$19K
27
$14K
28
$12K
29
$5K
30
$2K
31
$2K
32
$1.06K
33
$1K
34
$1K
35
$1K
36
$1K
37
–
38
–
39
–
40
–
1
2